The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis
- 8 May 2017
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 37 (2) , 515-526
Abstract
Patients with rheumatoid arthritis (RA) have higher aortic stiffness and cardiovascular risk. Tumor necrosis factor alpha (TNF-a) antagonists reduce inflammation in RA and are indicated for the treatment of patients with severe active rheumatoid disease. However, it is debatable if they have favorable effects on cardiovascular health. The present meta-analysis evaluates the effect of TNF-a antagonists on aortic stiffness and wave reflections, predictors of cardiovascular events and mortality, in RA patients. A search of PubMed, Cohrane, and Embase databases was conducted to identify studies into the effect of TNF-a antagonists on aortic stiffness in RA patients. Aortic stiffness and wave reflections were assessed by aortic (carotid-femoral [cf]) pulse wave velocity (PWV) and augmentation index (AIx), respectively. cfPWV significantly improved following TNF-a antagonist treatment (mean change: −0.53 m/s, 95% CI: −0.833 to −0.218, p = 0.001), independently of age and clinical response to treatment. A more prominent reduction in cfPWV was associated with etanercept/adalimumab (mean difference: −0.62 m/s, 95% CI: −0.968 to −0.272 m/s, p < 0.001) versus infliximab (mean difference: −0.193 m/s, 95% CI: −0.847 to 0.462 m/s, p = 0.564). TNF-a antagonist treatment induced a significant improvement in AIx (mean change: −1.48%, 95% CI: −2.89 to −0.078%, p = 0.039), but this reduction was influenced by age and clinical response to treatment. The balance of evidence suggests that TNF-a antagonists may have a beneficial effect on aortic stiffness and, therefore, on cardiovascular risk. However, larger, longitudinal studies are warranted to confirm such findings.Keywords
This publication has 42 references indexed in Scilit:
- Etanercept normalises left ventricular mass in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2013
- Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled studyAmerican Journal of Hypertension, 2012
- Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximabClinical Rheumatology, 2010
- Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2009
- Infliximab improves vascular stiffness in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2009
- The relationship between aortic augmentation index and pulse wave velocity: an invasive studyJournal Of Hypertension, 2007
- Effect of anti-TNFα treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritisLife Sciences, 2006
- Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertensionJournal Of Hypertension, 2006
- Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritisRheumatology, 2005
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994